ALLAY GEL CAP Trademark

Trademark Overview

On Wednesday, July 12, 2023, a trademark application was filed for ALLAY GEL CAP with the United States Patent and Trademark Office. The USPTO has given the ALLAY GEL CAP trademark a serial number of 98082360. The federal status of this trademark filing is EX PARTE APPEAL PENDING as of Monday, January 13, 2025. This trademark is owned by Tulavi Therapeutics, Inc.. The ALLAY GEL CAP trademark is filed in the Pharmaceutical Products category with the following description:

Medical hydrogel for protecting nerve ends and preventing the development of symptomatic neuroma
allay gel cap

General Information

Serial Number98082360
Word MarkALLAY GEL CAP
Filing DateWednesday, July 12, 2023
Status760 - EX PARTE APPEAL PENDING
Status DateMonday, January 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical hydrogel for protecting nerve ends and preventing the development of symptomatic neuroma
NOT AVAILABLE"GEL CAP"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 18, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTulavi Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLos Gatos, CA 95032

Trademark Events

Event DateEvent Description
Tuesday, December 12, 2023NON-FINAL ACTION WRITTEN
Saturday, July 15, 2023NEW APPLICATION ENTERED
Tuesday, July 18, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 30, 2023ASSIGNED TO EXAMINER
Tuesday, December 12, 2023NON-FINAL ACTION E-MAILED
Tuesday, December 12, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 12, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, March 12, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, June 12, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 12, 2024FINAL REFUSAL WRITTEN
Friday, July 12, 2024FINAL REFUSAL E-MAILED
Wednesday, June 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 12, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, October 11, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Sunday, January 12, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, January 12, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, January 12, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, January 13, 2025EXPARTE APPEAL RECEIVED AT TTAB
Monday, January 13, 2025EX PARTE APPEAL-INSTITUTED
Monday, January 13, 2025JURISDICTION RESTORED TO EXAMINING ATTORNEY
Friday, October 11, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Related Keywords

allay development symptomatic neuroma preventing ends hydrogel protecting nerve medical